There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...

To improve vaccine responses in older people, several strategies are under exploration. Adjuvants, which enhance immune responses, are being incorporated into vaccines to boost their efficacy. For ...

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...

A live-attenuated RSV vaccine to reduce medically attended RSV infection among older infants and ... Global introduction of mAbs should be monitored with global genomic surveillance, such as the ...

FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...

FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...

The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...

FLUMIST ® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

FluMist approved for self-administration in the US Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection FluMist ...

Americans may finally be able to self-administer a flu vaccine at home, with the FDA approving the nasal spray FluMist for ...